Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma is a research paper published in Pharmaceutics (2021). On theSindex it has a DataRank of 0. It has been cited 63 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: SC2 GM130478
NIH HHS
Grant: SC2 GM130478-01A1
National Institutes of Health
Grant: 5SC2GM130478-02
Oral nanoformulation for the treatment of BRAF inhibitor resistant melanoma
FWCI
3.11
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals